About this trial
This study will evaluate the clinical performance, Streptococcus mutans count, and salivary pH for Cention-N, Zirconomer, and resin-modified glass ionomer in Class I restoration of primary molars.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Children aged between 4-9 years.
Children who have Class I lesions in both the maxillary and mandibular arches.
Primary molar teeth had class I carious lesions in occlusal pits and fissures; the gap between intercuspal surfaces should not be exceeded during cavity preparation.
Primary molars free of periapical pathosis.
Disqualifiers
Primary molars with preapical pathosis or hypersensitivity.
Primary molars with periodontal diseases or mobile molar tooth that indicated for extraction.
Nonfunctioning teeth with no opposing dentition; heavy occlusion or signs of severe attrition; and endodontically treated teeth.
Trial design
Parallel
Treatments tested in this trial
Cention-N
DeviceClass I cavity restoration using Cention-N self-curing resin-based dental restorative material according to the manufacturer's instructions.
Zirconomer
DeviceClass I cavity restoration using Zirconomer zirconia-reinforced glass ionomer restorative material according to the
Resin-Modified Glass Ionomer
DeviceClass I cavity restoration using Resin-Modified Glass Ionomer (RMGI) restorative material according to the manufacturer's instructions
Treatment groups
Trial outcomes
Primary outcomes
Clinical Performance of Restorations
Evaluation of the clinical performance of restorations using modified USPHS (FDI) criteria. It systematically grades how restorative materials (like composite resins, glass ionomers, and ceramics) perform in the mouth over time
Secondary outcomes
Streptococcus Mutans Count
Assessment of Streptococcus mutans bacterial count in saliva/plaque samples expressed in CFU/mL will be recorded.
Salivary pH Level
Salivary pH changes will be measured using a digital pH meter.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Galal Ali Mohamed Ebaid
Lead sponsor
Al-Azhar University
Sponsor institution